tiprankstipranks
Cizzle Biotechnology Holdings PLC (GB:CIZ)
LSE:CIZ

Cizzle Biotechnology Holdings PLC (CIZ) Income Statement

3 Followers

Cizzle Biotechnology Holdings PLC Income Statement

Last quarter (Q2 2022), Cizzle Biotechnology Holdings PLC's total revenue was £―, a decrease of ― from the same quarter last year. In Q2, Cizzle Biotechnology Holdings PLC's net income was £―. See Cizzle Biotechnology Holdings PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
----£ 0.00£ 74.00K
Cost of Revenue
----£ 0.00£ 29.00K
Gross Profit
----£ 0.00£ 45.00K
Operating Expense
-£ 963.00K£ 851.00K£ 229.00K£ 356.00K£ 1.28M
Operating Income
-£ -963.00K£ -851.00K£ -229.00K£ -356.00K£ -1.23M
Net Non Operating Interest Income Expense
----£ 2.00£ 0.00
Other Income Expense
------
Pretax Income
-£ -963.00K£ -3.96M£ -306.00K£ -832.00K£ -1.73M
Tax Provision
-£ -51.00K£ -37.00K-£ 0.00£ -118.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ -912.00K£ -3.92M£ -306.00K£ -832.00K£ -2.06M
Basic EPS
--£ -0.02£ -0.02£ 0.00-
Diluted EPS
--£ -0.02£ -0.02£ 0.00-
Basic Average Shares
-£ 291.32M£ 160.52M£ 12.41M£ 253.45M-
Diluted Average Shares
-£ 291.32M£ 160.52M£ 12.41M£ 253.45M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-----£ 66.00K
Total Expenses
-£ 963.00K£ -851.00K£ -229.00K£ 356.00K£ 1.31M
Net Income From Continuing And Discontinued Operation
-£ -912.00K£ -3.92M£ -306.00K£ -832.00K£ -2.06M
Normalized Income
-£ -1.01M£ -888.00K£ -170.86K£ -356.00K£ -1.15M
Interest Expense
-----£ 0.00
EBIT
-£ -963.00K£ -3.96M£ -306.00K£ -356.00K£ -1.73M
EBITDA
-£ -963.00K£ -3.96M£ -306.00K£ -356.00K£ -1.11M
Currency in GBP

Cizzle Biotechnology Holdings PLC Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis